首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1663502

數位生物標記市場，按類型、按應用、按最終用途、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Digital Biomarkers Market, By Type, By Application, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: 2025年01月04日 | 出版商:

AnalystView Market Insights | 英文 280 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告重點

2024 年數位生物標記市場規模價值為 35.4054 億美元，2025 年至 2032 年期間的複合年成長率為 22.90%。

數位生物標記市場-市場動態

越來越關注遠端患者監控以推動市場成長

人們對遠端病人監控（RPM）的日益關注極大地推動了數位生物標記市場的發展。 RPM 涉及使用數位技術（例如穿戴式裝置、行動應用程式和感測器）來監測傳統臨床環境以外的患者健康狀況。隨著向以患者為中心的護理模式的轉變以及慢性病的增多，RPM 使醫療保健提供者能夠即時追蹤患者的健康狀況，從而及時干預並更好地管理糖尿病、高血壓和心血管疾病等病症。推動 RPM 採用的關鍵因素是對個人化和持續醫療保健的需求不斷成長。數位生物標記提供連續、即時的資料，從而實現更有針對性的治療並改善患者的治療效果。根據美國衛生與公眾服務部的數據，RPM 已證明可將醫院再入院率降低 25%，並透過減少親自就診的需求來降低醫療成本。這證明了 RPM 在改善病患照護和最佳化醫療資源利用方面的有效性。此外，持續的 COVID-19 疫情加速了遠端監控的需求，患者和醫療保健提供者正在尋求比面對面就診更安全的替代方案。慢性病的日益流行，加上穿戴式裝置的技術進步，進一步推動了數位生物標記市場的發展，改變了醫療保健的未來。

數位生物標記市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 22.90%
根據類型細分，預計生理學將在 2024 年佔據最大市場佔有率
根據最終用途細分，醫療保健提供者是 2024 年的領先細分市場
從地區來看，北美是 2024 年最大的收入來源

數位生物標記市場-細分分析：

全球數位生物標記市場根據類型、應用、最終用途和地區進行細分。

依類型，市場分為三類：生理、行為、認知。生理生物標記佔據市場主導地位，因為它們能夠提供即時、準確的生命徵象洞察，例如心率、血壓和體溫，這對於監測慢性病至關重要。這些生物標記廣泛應用於穿戴式裝置和遠端監控解決方案，使其成為個人化醫療的基石。

根據最終用途，市場分為三類：醫療保健提供者、製藥公司、研究機構。醫療保健提供者在市場中佔據主導地位，因為他們在利用數位生物標記進行患者監測、診斷和治療最佳化方面發揮關鍵作用。他們採用這些技術，實現即時資料追蹤、早期疾病檢測和個人化治療計劃，從而增強患者護理，推動市場成長。

數位生物標記市場-地理洞察

數位生物標記市場表現出明顯的地理差異，北美由於其先進的醫療基礎設施、穿戴式技術的廣泛採用以及政府對數位健康計劃的不斷增加的支持而引領市場。美國處於領先地位，這得益於慢性病的高發性、遠距醫療的進步以及對醫療創新的大量投資。此外，美國政府的《21世紀治癒法案》等政策提倡使用數位健康工具，推動了數位生物標記的採用。歐洲緊隨其後，因為該地區越來越重視以患者為中心的醫療保健和遠端患者監控。德國和英國等國家擴大將數位生物標記融入臨床實踐，旨在加強個人化醫療並改善慢性病管理。在亞太地區，由於醫療保健支出的增加、人們對慢性病管理的認知的不斷提高以及技術的進步，市場正在迅速擴張。日本、中國和印度等國家正在採用數位健康解決方案來管理日益加重的疾病負擔並改善醫療保健服務。中東和非洲 (MEA) 也正在經歷成長，儘管速度較慢，因為數位醫療的採用仍處於早期階段，但隨著政府支持的舉措和醫療保健系統的改善，其發展勢頭強勁。

數位生物標記市場-競爭格局：

數位生物標記市場的競爭格局由多種參與者組成，包括科技公司、醫療保健提供者和研究機構。該領域的公司正專注於創新和策略合作夥伴關係，以擴大其產品範圍。主要參與者正在利用與醫療機構的合作，將數位生物標記整合到臨床工作流程中，增強其在患者監測和疾病管理中的實用性。此外，隨著企業尋求加強其市場地位和提高其技術能力，併購趨勢也日益成長。該公司還專注於產品開發，採用先進的人工智慧演算法、機器學習和資料分析來提高數位生物標記的準確性和預測能力。市場高度分散，參與者在技術進步、易於整合、法規遵循和成本效益等因素上競爭。隨著個人化醫療的重要性日益增加，數位生物標記正成為管理慢性病的關鍵組成部分，這推動了對創新解決方案的需求。此外，受穿戴式裝置、行動應用程式和感測器技術進步的推動，市場正在見證大量新創企業的湧入，這對傳統參與者提出挑戰，迫使他們適應不斷發展的醫療保健格局。

介紹
- 按地區分類的細分市場佔有率分析
北美洲
- 概述
- 北美數位生物標記物主要製造商
- 北美市場規模及預測（按國家/地區）
- 北美市場規模和預測（按類型）
- 北美市場規模與預測，按應用分類
- 北美市場規模及預測（依最終用途分類）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲數位生物標記物主要製造商
- 歐洲市場規模及預測（按國家）
- 歐洲市場規模與預測（按類型）
- 歐洲市場規模和預測，按應用
- 歐洲市場規模及預測（依最終用途）
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 瑞典
- 俄羅斯
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區數位生物標記主要製造商
- 亞太地區市場規模及預測（依國家/地區分類）
- 亞太地區市場規模及預測（按類型）
- 亞太地區市場規模及預測（按應用分類）
- 亞太地區市場規模及預測（依最終用途分類）
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 印尼
- 泰國
- 菲律賓
- 亞太地區其他地區
拉丁美洲 (LATAM)
- 概述
- 拉丁美洲數位生物標記物主要製造商
- 拉丁美洲市場規模及預測（按國家/地區）
- 拉丁美洲市場規模及預測（按類型）
- 拉丁美洲市場規模及預測（按應用分類）
- 拉丁美洲市場規模及預測（依最終用途分類）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 概述
- 中東和非洲數位生物標記主要製造商
- MEA 市場規模及預測（依國家/地區分類）
- MEA 市場規模和預測（按類型）
- MEA 市場規模及預測（按應用）
- MEA 市場規模及預測（依最終用途分類）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 其他地區

第 11 章：關鍵供應商分析-數位生物標記產業

競爭儀錶板
- Competitive Benchmarking
- Competitive Positioning
公司簡介
- Biofourmis, Inc.
- Roche Holding AG
- Koneksa Health, Inc.
- Philips Healthcare
- Abbott Laboratories
- Google LLC
- Biogen, Inc.
- Garmin Ltd.
- Apple Inc.
- Medtronic PLC
- Chrono Therapeutics, Inc.
- Senseonics Holdings, Inc.
- Proteus Digital Health, Inc.
- Omron Healthcare Co., Ltd.
- ActiGraph, LLC
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4690

REPORT HIGHLIGHT

Digital Biomarkers Market size was valued at US$ 3,540.54 Million in 2024, expanding at a CAGR of 22.90% from 2025 to 2032.

Digital biomarkers are measurable indicators of biological processes, conditions, or diseases, which are captured and tracked using digital technologies such as wearables, mobile apps, and remote monitoring devices. These biomarkers provide real-time, continuous, and objective data about an individual's health status. Unlike traditional biomarkers, which are often derived from blood samples or clinical tests, digital biomarkers offer a more dynamic and non-invasive way to monitor health. The need for digital biomarkers arises from the growing demand for personalized healthcare and early disease detection. Traditional clinical visits can be infrequent, leading to gaps in understanding a patient's condition. Digital biomarkers bridge this gap by enabling continuous monitoring, helping detect health issues before they manifest with severe symptoms. They also facilitate timely interventions, improving patient outcomes. The importance of digital biomarkers lies in their potential to revolutionize healthcare. They provide accurate, real-time insights into an individual's health, allowing for personalized treatment plans and enabling the monitoring of chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders. Furthermore, digital biomarkers can enhance clinical trials, offering better data for assessing drug efficacy and safety. They are also crucial in promoting preventive care by tracking early signs of diseases, thus helping in proactive health management.

Digital Biomarkers Market- Market Dynamics

Increasing focus on remote patient monitoring to drive the market growth

The growing focus on remote patient monitoring (RPM) is significantly driving the Digital Biomarkers market. RPM involves the use of digital technologies, such as wearables, mobile applications, and sensors, to monitor patients' health status outside of traditional clinical settings. With the shift towards more patient-centric care models and the rise of chronic diseases, RPM enables healthcare providers to track patient health in real-time, leading to timely interventions and better management of conditions such as diabetes, hypertension, and cardiovascular diseases. One key factor driving RPM adoption is the increasing demand for personalized and continuous healthcare. Digital biomarkers provide continuous, real-time data, allowing for more tailored treatments and improving patient outcomes. According to the U.S. Department of Health and Human Services, RPM has been shown to reduce hospital readmission rates by 25% and lower healthcare costs by reducing the need for in-person visits. This demonstrates the effectiveness of RPM in both improving patient care and optimizing healthcare resource utilization. Moreover, the ongoing COVID-19 pandemic has accelerated the need for remote monitoring, with patients and healthcare providers seeking safer alternatives to in-person visits. The growing prevalence of chronic diseases, coupled with technological advancements in wearable devices, further fuels the market for digital biomarkers, transforming the future of healthcare.

Digital Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.90% over the forecast period (2025-2032)
Based on Type segmentation, Physiological was predicted to show maximum market share in the year 2024
Based on End-Use segmentation, Healthcare Providers was the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024

Digital Biomarkers Market- Segmentation Analysis:

The Global Digital Biomarkers Market is segmented on the basis of Type, Application, End-Use and Region.

The market is divided into three categories based on Type: Physiological, Behavioral, Cognitive. Physiological biomarkers dominate the market due to their ability to provide real-time, accurate insights into vital signs like heart rate, blood pressure, and temperature, which are essential for monitoring chronic conditions. These biomarkers are widely adopted in wearable devices and remote monitoring solutions, making them a cornerstone of personalized healthcare.

The market is divided into three categories based on End-Use: Healthcare Providers, Pharmaceutical Companies, Research Organizations. Healthcare Providers dominate the market due to their critical role in utilizing digital biomarkers for patient monitoring, diagnosis, and treatment optimization. Their adoption of these technologies enhances patient care by enabling real-time data tracking, early disease detection, and personalized treatment plans, driving market growth.

Digital Biomarkers Market- Geographical Insights

The Digital Biomarkers market shows significant geographical variation, with North America leading the market due to the presence of advanced healthcare infrastructure, widespread adoption of wearable technologies, and increasing government support for digital health initiatives. The U.S. is at the forefront, driven by the high prevalence of chronic diseases, advancements in telemedicine, and substantial investments in healthcare innovation. Moreover, the U.S. government's policies, such as the 21st Century Cures Act, promote the use of digital health tools, boosting the adoption of digital biomarkers. Europe follows closely, driven by the region's growing emphasis on patient-centered healthcare and remote patient monitoring. Countries like Germany and the UK are increasingly integrating digital biomarkers into clinical practice, aiming to enhance personalized medicine and improve chronic disease management. In the Asia-Pacific region, the market is expanding rapidly due to increasing healthcare spending, growing awareness about chronic disease management, and technological advancements. Countries like Japan, China, and India are adopting digital health solutions to manage the rising burden of diseases and improve healthcare access. The Middle East and Africa (MEA) are also witnessing growth, albeit at a slower pace, as digital health adoption is still in the early stages but gaining momentum with government-backed initiatives and improving healthcare systems.

Digital Biomarkers Market- Competitive Landscape:

The competitive landscape of the Digital Biomarkers market is marked by a diverse range of players, including technology companies, healthcare providers, and research organizations. Companies in this space are focusing on innovation and strategic partnerships to expand their offerings. Key players are leveraging collaborations with healthcare institutions to integrate digital biomarkers into clinical workflows, enhancing their utility in patient monitoring and disease management. Moreover, there is a growing trend of mergers and acquisitions as companies seek to strengthen their market position and enhance their technological capabilities. Companies are also focusing on product development, incorporating advanced AI algorithms, machine learning, and data analytics to improve the accuracy and predictive power of digital biomarkers. The market is highly fragmented, with players competing on factors such as technological advancement, ease of integration, regulatory compliance, and cost-effectiveness. With the increasing importance of personalized healthcare, digital biomarkers are becoming a crucial component in managing chronic conditions, which drives the demand for innovative solutions. Additionally, the market is witnessing an influx of startups, driven by advancements in wearable devices, mobile applications, and sensor technologies, challenging traditional players to adapt to the evolving healthcare landscape.

Recent Developments:

In February 2024, Biofourmis secured four new agreements with top pharmaceutical companies, expanding its role in digital clinical trials and the development of digital biomarkers, particularly in oncology. The company's expertise in digital biomarkers and decentralized clinical trials is driving the adoption of its platform, which aims to reduce study timelines and enhance participant engagement through remote monitoring and in-home services.
In November 2024, Neuron23 partnered with Roche to utilize its digital biomarker and device as a primary endpoint in the Phase 2 NEULARK clinical trial for Parkinson's disease. The use of Roche's navify digital biomarker solution will enhance precision, reduce patient burden, and improve clinical trial efficiency by offering continuous, objective symptom tracking compared to traditional clinical rating scales.
In December 2024, Koneksa published a new data syndication model to enhance drug discovery by using digital health data for clinical and translational science. The model facilitates collaboration among stakeholders like biopharmaceutical companies, enabling faster study launches and real-time data sharing to validate digital health measures more efficiently. This approach is exemplified by the LEARNS study, which is evaluating Parkinson's disease progression using wearable devices and digital health tools to speed up the validation of digital biomarkers in clinical trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Biofourmis, Inc.
Roche Holding AG
Koneksa Health, Inc.
Philips Healthcare
Abbott Laboratories
Google LLC
Biogen, Inc.
Garmin Ltd.
Apple Inc.
Medtronic PLC
Chrono Therapeutics, Inc.
Senseonics Holdings, Inc.
Proteus Digital Health, Inc.
Omron Healthcare Co., Ltd.
ActiGraph, LLC
Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Physiological
Behavioral
Cognitive
Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

Wearable Devices
Mobile Applications
Remote Monitoring Systems
Sensor Technologies
Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Healthcare Providers
Pharmaceutical Companies
Research Organizations
Others

GLOBAL DIGITAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Digital Biomarkers Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Digital Biomarkers Market Snippet by Type
- 2.1.2. Digital Biomarkers Market Snippet by Application
- 2.1.3. Digital Biomarkers Market Snippet by End-Use
- 2.1.4. Digital Biomarkers Market Snippet by Country
- 2.1.5. Digital Biomarkers Market Snippet by Region
2.2. Competitive Insights

3. Digital Biomarkers Key Market Trends

3.1. Digital Biomarkers Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Digital Biomarkers Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Digital Biomarkers Market Opportunities
3.4. Digital Biomarkers Market Future Trends

4. Digital Biomarkers Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Digital Biomarkers Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Digital Biomarkers Market Landscape

6.1. Digital Biomarkers Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Digital Biomarkers Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 7.1.2. Physiological
- 7.1.3. Behavioral
- 7.1.4. Cognitive
- 7.1.5. Others

8. Digital Biomarkers Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Wearable Devices
- 8.1.3. Mobile Applications
- 8.1.4. Remote Monitoring Systems
- 8.1.5. Sensor Technologies
- 8.1.6. Others

9. Digital Biomarkers Market - By End-Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
- 9.1.2. Healthcare Providers
- 9.1.3. Pharmaceutical Companies
- 9.1.4. Research Organizations
- 9.1.5. Others

10. Digital Biomarkers Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Digital Biomarkers Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Digital Biomarkers Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Digital Biomarkers Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Digital Biomarkers Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Digital Biomarkers Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Digital Biomarkers Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Biofourmis, Inc.
- 11.2.2. Roche Holding AG
- 11.2.3. Koneksa Health, Inc.
- 11.2.4. Philips Healthcare
- 11.2.5. Abbott Laboratories
- 11.2.6. Google LLC
- 11.2.7. Biogen, Inc.
- 11.2.8. Garmin Ltd.
- 11.2.9. Apple Inc.
- 11.2.10. Medtronic PLC
- 11.2.11. Chrono Therapeutics, Inc.
- 11.2.12. Senseonics Holdings, Inc.
- 11.2.13. Proteus Digital Health, Inc.
- 11.2.14. Omron Healthcare Co., Ltd.
- 11.2.15. ActiGraph, LLC
- 11.2.16. Others